- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02293083
Hyaluronidase for Trigger Point Injection in Myofascial Pain Syndrome
Effect of Hyaluronidase Addition to Lidocaine for Trigger Point Injection in Myofascial Pain Syndrome
Myofascial pain syndrome (MPS) is the most common cause of persistent regional pain characterized by myofascial trigger points. Trigger point injection (TPI) using local anesthetics is one of the most effective methods for treatment of MPS, and steroids or botulinum toxin can be added to local injections .
Recent study suggested that the hyaluronan (HA) could be the basis of myofascial pain. HA within the deep fascia facilitates the free sliding of two adjacent fibrous fascial layers. If the HA assumes a more packed conformation, or more generally, if the loose connective tissue inside the fascia alters its density, the behavior of the entire deep fascia and the underlying muscle would be compromised.
The investigators anticipated that hyaluronidase could decrease the viscosity of HA near the muscle and fascia of trigger points. Meanwhile, hyaluronidase is thought to promote the spread of local anesthetic solution by hydrolyzing glycosidic bonds within HA. Hyaluronidase was shown to be effective in retro- and peribulbar block for ophthalmologic surgery or reducing tissue edema in dermatology, and adhesiolysis for some interventional pain managements.
However, the effect of the addition of hyaluronidase to local anesthetics during TPI has not been studied. The investigators aimed to compare the efficacy of TPI with the addition of hyaluronidase compared to local anesthetic alone on pain and quality of life in MPS patients.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study approval was obtained from Institutional Review Board (IRB) of Samsung medical center, and written informed consent was obtained from all participants.
The required sample size was determined by power analysis on the basis of a previous study. The primary outcome was pain intensity in the posterior neck and upper back after TPI using verbal numerical rating scale (VNRS). The standard deviation of VNRS was assumed to be 20. Power calculations indicated that detecting 20 points difference in VNRS between the two groups (with α = 0.05 and β = 0.1) would require a sample of 29 subjects for each group. To account for dropouts, 33 subjects were recruited for each group.
Group L received TPI with a 3.2 ml of a 1:1 mixture of 1% lidocaine and 0.9% normal saline. Group H received TPI with the same volume of solution supplemented with hyaluronidase (H-LASE®, 1500 iu, L&H Pharm., Seoul, Korea) 600 iu/ml. The investigators monitored vital sign and any signs of complications such as bleeding, hematoma, allergic reactions for 30 minutes. Treatment efficacy was evaluated by one of the authors (J.W.C.) using VNRS. To reduce bias, this evaluator and the participants were not informed of the assigned group.
Patients' characteristics such as age, height, weight, BMI and pretreatment neck disability index (NDI) and brief pain inventory (BPI) were analyzed by independent t-test. The sex distribution was analyzed by the chi-square test. P values were corrected by Bonferroni's method. Pretreatment VNRS and the duration of pain were evaluated by the Wilcoxon two-sample test. Repeated measures ANOVA was used to compare changes in the VNRS over time between the two groups. Pre- and post-TPI changes in NDI and BPI were compared between the two groups with the Wilcoxon signed rank test and the independent t-test, respectively. All analyses were performed with SPSS 18.0 (SPSS Inc., Chicago, IL, USA) statistical software. Significance was assumed for P values of less than 0.05.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults
- Aged 25-75 years
- Diagnosed with myofascial pain syndrome affecting both trapezius muscles
Exclusion Criteria:
- History of allergy to lidocaine or hyaluronidase
- Anticoagulant medication or antiplatelet agent within 5 days before the study
- Analgesic medication, including non-steroidal anti-inflammatory drugs, tramadol, acetaminophen, or opioids within 5 days of the study
- Pain related to trauma within 6 months before the study
- History of cervical or shoulder surgery
- TPI within 3 months in the same region
- Fibromyalgia
- Cervical radiculopathy or myelopathy
- Obesity, defined as body mass index of 27.5 or higher
- Other medical or psychological conditions (cancer, rheumatoid arthritis, endocrine disease, major depression, schizophrenia)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Lidocaine
Group L received trigger point injection with a 3.2 ml of a 1:1 mixture of 1% lidocaine and 0.9% normal saline
|
|
Experimental: Hyaluronidase
Group H received trigger point injection with the same volume of solution supplemented with hyaluronidase (H-LASE®, 1500 iu, L&H Pharm., Seoul, Korea) 600 iu/ml
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Degree of pain as measured by the verbal numerical rating scale
Time Frame: within 2 weeks after intervention
|
within 2 weeks after intervention
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201003046001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myofascial Pain Syndrome
-
Medical University of SilesiaCompletedMyofascial Trigger Point Pain | Myofascial Pain Syndrome of Neck | Myofascial Trigger Point SyndromePoland
-
Santa Casa da Misericordia do Rio de Janeiro HospitalUnknownFibromyalgia | Myofascial Pain Syndrome, Diffuse | Diffuse Myofascial Pain Syndrome | Fibromyalgia-Fibromyositis Syndrome | Fibromyositis-Fibromyalgia SyndromeBrazil
-
Universidad Complutense de MadridRecruitingTrigger Point Pain, Myofascial | Myofascial Pain Syndrome of Neck | Myofacial PainSpain
-
Sobet AGLa Tour Hospital; Klinikum Klagenfurt am Wörthersee; Krankenhaus der Elisabethinen... and other collaboratorsRecruitingMyofascial Pain Syndrome - Lower Back | Myofascial Pain Syndrome - Neck | Myofascial Pain Syndrome - Tension HeadacheAustria, Switzerland
-
Cairo UniversityCompletedCervical Myofascial Pain SyndromeEgypt
-
Riphah International UniversityCompletedMyofascial Pain Syndrome of NeckPakistan
-
Istanbul Physical Medicine Rehabilitation Training...CompletedMyofascial Pain Syndrome of NeckTurkey
-
Kars State HospitalCompleted
-
Taipei Medical University WanFang HospitalRecruitingMyofascial Pain Syndrome of NeckTaiwan
-
King Faisal Specialist Hospital & Research CenterRecruitingMyofascial Pain Syndrome of NeckSaudi Arabia
Clinical Trials on trigger point injection
-
Rutgers UniversityCompletedTrigger Point Pain, Myofascial | Nerve Block | Myofascial Pain - Dysfunction Syndrome of TMJ
-
Istanbul UniversityEnrolling by invitation
-
Hermano Miguel FoundationEcuadorian Federation of Physiotherapy, Tungurahua Branch; Technical University...Unknown
-
University of Colorado, DenverCompletedMyofascial Pain | Tension-type HeadacheUnited States
-
Scott and White Hospital & ClinicCompleted
-
Riphah International UniversityRecruitingMyofascial Trigger Point Pain | Chronic Pelvic PainPakistan
-
Anglo-European College of ChiropracticUnknownSpinal Manipulable Lesion | Somatic DysfunctionUnited Kingdom
-
Universidad Católica de ÁvilaCompletedShoulder TendinopathySpain
-
William Beaumont Army Medical CenterCompletedSub-acute and Chronic Low Back PainUnited States
-
University of Colorado, DenverNational Center for Complementary and Integrative Health (NCCIH)CompletedTension-type HeadacheUnited States